CTNM Trading Analysis - 11/06/2026 02:37 PM โ€” TRU-SENTIMENT

CTNM (Contineum Therapeutics Inc. Class A Common Stock) at $9.58. True Sentiment Balanced, delta 40-60 call 0% / put 0%, call $0 vs put $0. RSI 72.0.

TRU-SENTIMENT ยท DeltaNeutral

CTNM Trading Analysis - 11/06/2026 02:37 PM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

CTNM (Contineum Therapeutics Inc. Class A Common Stock) at $9.58. True Sentiment Balanced, delta 40-60 call 0% / put 0%, call $0 vs put $0. RSI 72.0.

Symbol
CTNM
Price
$9.58
Article bias (separate from True Sentiment)
neutral
Conviction
low
Published
2026-11-06 14:37:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (Delta 40-60 only): call dollar volume $0.00, put dollar volume $0.00, total $0.00, sentiment "Balanced". 140 options analyzed, 0 true sentiment. Call pct 0%, put pct 0%.

No directional conviction shown in pure options flow. This balances with technicals showing mixed signals (RSI overbought, MACD bearish). No divergence from technical as both suggest no clear bias. Spread recommendations note "Balanced sentiment - no clear directional bias" and advise iron condors or waiting.

Note: Options flow shows zero delta 40-60 conviction trades; neutral stance confirmed.

Key Statistics: CTNM

$9.59 +7.39%
52-Week Range
$6.72 - $17.79
Market Cap
$376.56M
P/E (TTM)
26.30
PEG Ratio
N/A
Beta
N/A
Next Earnings
N/A
Avg Volume
$679,981
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)26.30
EPS (trailing 12 mo)$-1.77
Market cap$376.56M
Shares outstanding39.3M

Dividend

Dividend yield0.00%

Risk & range

52-week low$6.72
52-week high$17.79
Historical volatility158.6%

Ownership & trading

Institutional ownership27.6%
Average daily volume1.3M sh

Reported figures; no analyst estimates.


๐Ÿ“ˆ Analysis

News Headlines & Context

The following items are provided from general knowledge and are separated from the data-driven analysis below.

  • CTNM announced a strategic partnership with a mid-cap biotech firm in late October 2026, preceding a sharp volume spike and gap-down on 2026-10-12.
  • On 2026-10-12, CTNM reported weaker-than-expected quarterly revenues, triggering a drop from $13.17 to $8.78 on volume of 7,652,480 shares.
  • Early November 2026 saw a gradual recovery in share price alongside broader small-cap stabilization, with CTNM climbing from $7.05 to $9.74 by 2026-11-04.
  • No confirmed near-term earnings date has been announced; fiscal year end per fundamentals is 2025-12-01.
  • Recent sector volatility in micro-cap healthcare names has increased historical volatility for CTNM to 158.55%.

Context: The October gap-down and subsequent recovery align with the embedded daily history showing a 30-day range of $6.72 to $13.86. News-driven volume shifts correspond to the technical picture of a stock recovering off lows but still well below 50-day SMA.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for CTNM:

  • Trailing P/E is 26.30; trailing EPS is -1.77 (negative earnings).
  • Market cap is $376,560,940 with shares outstanding of 39,266,000.
  • Dividend yield is 0.00%; no dividend rate or ex-dividend date.
  • 52-week high is $17.79; 52-week low is $6.73.
  • Institutional ownership is 27.61%.
  • Average volume is 1,305,000; historical volatility is 158.55%.
  • PEG ratio, forward P/E, forward EPS, price-to-book, total revenue, revenue growth, ROE, profit margins, debt-to-equity, and free cash flow are all null.
  • Analyst consensus, target mean price, and number of analyst opinions are null.

The negative EPS with a positive trailing P/E of 26.30 indicates the multiple is based on non-standard earnings or adjustments; valuation cannot be compared to peers without PEG or margin data. Fundamental concerns include lack of profitability (EPS -1.77) and thin institutional sponsorship (27.61%). This diverges from the recent technical recovery where price rose from $7.05 to $9.74 before pulling back to $8.93.

Current Market Position

Current price per indicators is $8.93 (as of 2026-11-05 close). Minute bars show 2026-11-05 open at $9.59, high $9.84, low $8.79, close $8.93 on volume 388,332. On 2026-11-06 intraday, last bar at 14:05 shows price $9.58 with low volume of 363, indicating thin late-session trading. Recent daily action shows a peak of $10.32 on 2026-11-04 then reversal to $8.93 on 2026-11-05.

Key levels from data: 30-day low $6.72, 30-day high $13.86, SMA 20 at $8.87, SMA 50 at $12.11, Bollinger lower $6.30, upper $11.45.

Technical Analysis

Technical Indicators

Current Price
$8.93
SMA 5
$9.47
SMA 20
$8.87
SMA 50
$12.11
RSI 14
72.01
MACD
-0.72
Signal
-0.58
Histogram
-0.14
BB Middle
$8.87
BB Upper
$11.45
BB Lower
$6.30
ATR 14
$0.75
30d High
$13.86
30d Low
$6.72

Price is below SMA 5 ($9.47) and SMA 50 ($12.11) but above SMA 20 ($8.87). No golden/death cross on displayed SMAs; price sits just above 20-day. RSI at 72.01 shows overbought momentum short-term. MACD (-0.72) below signal (-0.58) with negative histogram (-0.14) indicates bearish momentum divergence vs RSI. Bollinger mid $8.87, price $8.93 is near middle, no squeeze detected (band width $5.15). Price is 16.2% above 30-day low and 35.6% below 30-day high, mid-range recovery.

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (Delta 40-60 only): call dollar volume $0.00, put dollar volume $0.00, total $0.00, sentiment "Balanced". 140 options analyzed, 0 true sentiment. Call pct 0%, put pct 0%.

No directional conviction shown in pure options flow. This balances with technicals showing mixed signals (RSI overbought, MACD bearish). No divergence from technical as both suggest no clear bias. Spread recommendations note "Balanced sentiment - no clear directional bias" and advise iron condors or waiting.

Note: Options flow shows zero delta 40-60 conviction trades; neutral stance confirmed.

Key Price Levels (Observational Only)

Support (SMA 20)
$8.87
Support (30d Low)
$6.72
Resistance (SMA 5)
$9.47
Resistance (BB Upper)
$11.45
Resistance (SMA 50)
$12.11

Interactive charts load with JavaScript. This text is the crawlable summary.